Skip to main content

Organ simulator chips hope to revolutionize drug development, reduce animal testing

Image used with permission by copyright holder

The folks at PETA, it’s time to rejoice. A new technology by a team of Harvard University bioengineers could soon replace animal testing with organ-simulating chips. Programmed to replicate the functionalities of human organs, the team has developed several organ-on-a-chip variations so scientists can perform experiments using these chips instead of on live animals.

At the moment, researchers at Harvard’s Wyss Institute have come up with lung-on-a-chip, heart-on-a-chip, and most recently, gut-on-a-chip. The miniature simulators may be tiny, but all pack the full features of each organ represented, including live human cells growing within the chip. This involves the team replicating flexible human membranes to mimic a real organ system that cells require to survive.

Recommended Videos

“Because the models most often available to us today do not recapitulate human disease, we can’t fully understand the mechanisms behind many intestinal disorders, which means that the drugs and therapies we validate in animal models often fail to be effective when tested in humans,” said Wyss Founding Director Donald Ingber. “Having better, more accurate in vitro disease models, such as the gut-on-a-chip, can therefore significantly accelerate our ability to develop effective new drugs that will help people who suffer from these disorders.”

The chips can be readily tested like the same way experiments are conducted on human or animal subjects minus the need to prep. With the transparent chips, scientists can also observe the reactions to chemicals with ease and record how fast the effects take place. Another benefit to the chips include testing medicines for human diseases that do not have animal analogs, such as Crohn’s disease, reports Extreme Tech. Instead of sampling human subjects, which requires a large investment and is extremely high risk, the chips could bypass all these economical issues.

“It is very common for drugs to pass animal testing, but then fail on humans,” writes Extreme Tech’s Sebastian Anthony. “Removing animal testing from the equation would save money and time, and also alleviate any ethical concerns.”

The only issue is, of course, if the chips become more developed on a consumer-focused level — including the cosmetics industry. Sample products are applied to animals to check for any reactions at all, so pinpointing just one organ of the entire human body system could prove to provide limited results. Still, any alleviation to an already controversial practice is an innovative step toward the future. As long as no one is endangered along the way, we look forward to more types of organ-on-a-chip to see the kinds of results they can show under medicinal experiments.

Watch the video below to learn more about organ-on-a-chip technology by the team at Wyss Institute.

Natt Garun
Former Digital Trends Contributor
An avid gadgets and Internet culture enthusiast, Natt Garun spends her days bringing you the funniest, coolest, and strangest…
Hyundai Ioniq 5 sets world record for greatest altitude change
hyundai ioniq 5 world record altitude change mk02 detail kv

When the Guinness World Records (GWR) book was launched in 1955, the idea was to compile facts and figures that could finally settle often endless arguments in the U.K.’s many pubs.

It quickly evolved into a yearly compilation of world records, big and small, including last year's largest grilled cheese sandwich in the world.

Read more
Global EV sales expected to rise 30% in 2025, S&P Global says
ev sales up 30 percent 2025 byd sealion 7 1stbanner l

While trade wars, tariffs, and wavering subsidies are very much in the cards for the auto industry in 2025, global sales of electric vehicles (EVs) are still expected to rise substantially next year, according to S&P Global Mobility.

"2025 is shaping up to be ultra-challenging for the auto industry, as key regional demand factors limit demand potential and the new U.S. administration adds fresh uncertainty from day one," says Colin Couchman, executive director of global light vehicle forecasting for S&P Global Mobility.

Read more
Faraday Future could unveil lowest-priced EV yet at CES 2025
Faraday Future FF 91

Given existing tariffs and what’s in store from the Trump administration, you’d be forgiven for thinking the global race toward lower electric vehicle (EV) prices will not reach U.S. shores in 2025.

After all, Chinese manufacturers, who sell the least expensive EVs globally, have shelved plans to enter the U.S. market after 100% tariffs were imposed on China-made EVs in September.

Read more